News
Kenya: FHI 360 will build and strengthen a network of laboratories to test for antimicrobial-resistant bacteria
Photo Credit: Mbuto Machili/FHI 360 Antimicrobial resistance (AR) is a global health and development threat that leads to reduced effectiveness of antimicrobial agents and increases in morbidity, mortality and associated health care costs. To address the growing...
Needs for Upgraded Points of Entry (POE) Management in COVID-19 Pandemic-era India
The current volume, speed, and reach of travel in the world today is unprecedented. So too is the potential for infectious diseases to spread globally. Migration of humans has been the pathway for disseminating infectious diseases throughout recorded history and will...
Global Public Health Defenders: The Critical Role of Animal Health Laboratories in the Containment of Zoonoses
What are zoonotic diseases? Zoonotic diseases, also known as zoonoses, are diseases which are transmitted to humans from animals. They present a significant challenge to the public health of today and the future. Up to 60% of known human infectious diseases are of...
FHI 360’s Contribution Towards Mitigating the Antimicrobial Resistance (AMR) Problem: The African Context
Antimicrobial resistance (AMR) occurs naturally as infectious pathogens can adapt to their environment. However, it is exacerbated by inappropriate (misuse) and excessive (overuse) use of antimicrobials in the human healthcare, animal, and agriculture sectors…